Stockholders' Equity - Additional Information (Detail) (USD $)
|
1 Months Ended | 3 Months Ended | 4 Months Ended | 6 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 3 Months Ended | 12 Months Ended | 1 Months Ended | 12 Months Ended | 1 Months Ended | 4 Months Ended | 1 Months Ended | 1 Months Ended | 1 Months Ended | 0 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Oct. 30, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Oct. 31, 2012
|
Dec. 31, 2013
|
Dec. 31, 2012
|
Jul. 09, 2013
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Aug. 31, 2013
Second Tranche [Member]
|
Jun. 30, 2013
Second Tranche [Member]
|
Apr. 04, 2013
Third Tranche [Member]
|
Dec. 31, 2013
Third Tranche [Member]
|
Jun. 30, 2013
Third Tranche [Member]
|
Jun. 04, 2013
Third Tranche [Member]
|
Apr. 04, 2013
Second And Third Tranche [Member]
|
Jun. 30, 2013
Second And Third Tranche [Member]
|
Apr. 04, 2013
First Tranche [Member]
|
Jul. 09, 2013
Baytree Capital [Member]
|
Dec. 31, 2013
Baytree Capital [Member]
|
Jun. 14, 2013
Baytree Capital [Member]
|
Oct. 31, 2012
Common Stock [Member]
|
Oct. 31, 2012
Warrant [Member]
|
Jun. 30, 2013
Warrant [Member]
|
Jun. 14, 2012
Baytree [Member]
|
Dec. 14, 2013
Baytree [Member]
|
Jun. 14, 2013
Baytree [Member]
|
Jun. 14, 2013
Caro Capital LLC [Member]
|
Apr. 04, 2013
Caro Capital LLC [Member]
|
Dec. 31, 2013
Caro Capital LLC [Member]
|
Oct. 14, 2013
Catalyst Global LLC [Member]
|
Nov. 08, 2013
Catalyst Global LLC [Member]
First Tranche [Member]
|
Dec. 18, 2013
Institutional Analyst Holdings Inc [Member]
|
Dec. 18, 2013
Institutional Analyst Holdings Inc [Member]
First Tranche [Member]
|
Dec. 31, 2013
Options [Member]
|
Jun. 14, 2012
Advisory Agreement [Member]
|
Jun. 14, 2012
Advisory Agreement [Member]
Restricted Stock
|
Feb. 04, 2014
Subsequent Event [Member]
|
|
Stockholders Equity Note Disclosure [Line Items] | ||||||||||||||||||||||||||||||||||||||
Common stock, authorized | 145,000,000 | 145,000,000 | 145,000,000 | |||||||||||||||||||||||||||||||||||
Common stock, par value | $ 0.001 | $ 0.001 | $ 0.12 | $ 0.001 | $ 0.32 | $ 0.05 | $ 0.60 | |||||||||||||||||||||||||||||||
Preferred stock, authorized | 5,000,000 | 5,000,000 | 5,000,000 | |||||||||||||||||||||||||||||||||||
Preferred stock, par value | $ 0.001 | $ 0.001 | $ 0.001 | |||||||||||||||||||||||||||||||||||
Shares of common stocks issued | 32,000 | 32,000 | 2,353,093 | 48,287 | 100,000 | 100,000 | ||||||||||||||||||||||||||||||||
Advisory service agreement period | 6 years | |||||||||||||||||||||||||||||||||||||
Warrant to purchase restricted shares of common stock | 1,837,777 | |||||||||||||||||||||||||||||||||||||
Warrant term | 5 years | 5 years | ||||||||||||||||||||||||||||||||||||
Common stock initial exercise price | 0.41 | 0.41 | 0.41 | 0.06 | ||||||||||||||||||||||||||||||||||
Shares of common stock outstanding under the option plan | 5,078,361 | 3,415,053 | 5,078,361 | 3,415,053 | 2,527,389 | 4,536,949 | 3,010,973 | |||||||||||||||||||||||||||||||
Prepaid Advisory Fees | $ 3,258,000 | $ 747,000 | $ 5,000 | |||||||||||||||||||||||||||||||||||
Amortization of prepaid advisory fees | 815,000 | 825,000 | 830,000 | |||||||||||||||||||||||||||||||||||
Proceeds from Issuance or Sale of Equity | 980,000 | |||||||||||||||||||||||||||||||||||||
Common Stock Value | 48,000 | 48,000 | 47,000 | 44,000 | ||||||||||||||||||||||||||||||||||
Restricted Stock Per Contract Terms | 100,000 | |||||||||||||||||||||||||||||||||||||
Accrued expenses | 156,000 | 156,000 | 211,000 | 60,000 | 5,000 | |||||||||||||||||||||||||||||||||
Issuance Of Restricted Shares | 100,000 | 100,000 | 100,000 | 100,000 | 450,000 | 180,000 | 400,000 | |||||||||||||||||||||||||||||||
Issuance Of Restricted Stock Price Per Share | $ 0.08 | $ 0.50 | $ 0.05 | $ 0.06 | ||||||||||||||||||||||||||||||||||
Issuance Of Restricted Shares Value | 50,000 | 500,000 | 9,000 | 24,000 | ||||||||||||||||||||||||||||||||||
Exercisable options intrinsic value | 12,000 | 12,000 | ||||||||||||||||||||||||||||||||||||
Sale of Stock, Price Per Share | $ 0.05 | $ 0.05 | ||||||||||||||||||||||||||||||||||||
Share Based Compensation | 60,000 | 38,000 | 21,000 | |||||||||||||||||||||||||||||||||||
Share Based Compensation Weighted average Amortization Period | 8 years 3 months 22 days | |||||||||||||||||||||||||||||||||||||
Stock Issued During Period, Shares, Issued for Services | 100,000 | |||||||||||||||||||||||||||||||||||||
Consulting Expenses | 100,000 | 283,000 | 32,000 | |||||||||||||||||||||||||||||||||||
Warrants issued | 579,450 | 2,907,347 | 2,907,347 | |||||||||||||||||||||||||||||||||||
Debt Instrument, Decrease, Forgiveness | 400,000 | |||||||||||||||||||||||||||||||||||||
Debt Instrument, Debt Default, Amount | 1,000,000 | 1,000,000 | ||||||||||||||||||||||||||||||||||||
Equity Purchase price | 200,000 | |||||||||||||||||||||||||||||||||||||
Common Stock Shares Issued | 48,135,576 | 48,135,576 | 47,355,576 | |||||||||||||||||||||||||||||||||||
Common Stock Shares Outstanding | 48,135,576 | 48,135,576 | 47,355,576 | |||||||||||||||||||||||||||||||||||
Advisory Fees | 6,500 | 2,000 | 2,500 | |||||||||||||||||||||||||||||||||||
Common Stock, Par Or Stated Value Per Share | $ 0.001 | $ 0.001 | $ 0.12 | $ 0.001 | $ 0.32 | $ 0.05 | $ 0.60 | |||||||||||||||||||||||||||||||
Accrued Liabilities Current | 156,000 | 156,000 | 211,000 | 60,000 | 5,000 | |||||||||||||||||||||||||||||||||
Additional Issuance Of Restricted Shares | 400,000 | |||||||||||||||||||||||||||||||||||||
Gain Loss On Settlement Of Accrued Liability | $ 0 | $ 0 | $ 42,000 | $ 0 |